Potentiality of Cannabis as an Antibiotic (Antimicrobial) Agent

Wurgan Rahadian


Cannabis sativa, or widely known as ganja and other names in Indonesia, is a plant that could not be used in the health care system in Indonesia. It is because cannabis is still a Class 1 Narcotic. However, trends within the last few years show that cannabis has medicinal properties, and is already approved as medicine and (even) for recreational means in several nations/countriesThailand is the first nation in Southeast Asia that did. This article aims to emphasize the antimicrobial potential that cannabis has. Since conventional antibiotic is considered unable to provide, it is important to find another source to counter the high rates of antibiotic (antimicrobial) resistance. Moreover, this article is also aimed to introduce one of the potentials that cannabis have to Indonesia since scientific article written in Bahasa is rare.


cannabis; ganja; antimicrobial; antibiotics; antibacterial

Full Text:



Lancini G, Parenti F. Antibiotics: An Integrated View. NY, USA: Springer-Verlag; 1982. 264 p.

Madigan MT, Martinko JM, Stahl DA, Clark DP. Brock Biology of Microorganisms. 13th Edition. CA, USA: Pearson Education, Inc.; 2012. 1155 p.

Gilbert P. Principles of Microbial Pathogenicity and Epidemiology. In: Hugo WB, Russell AD, editors. Pharmaceutical Microbiology. 6th Edition. Oxford, UK: Blackwell Science, Ltd.; 1998. p. 75-88.

White RJ. The Early History of Antibiotic Discovery: Empiricism Ruled. In: Dougherty TJ, Pucci MJ, editors. Antibiotic Discovery and Development. NY, USA: Springer Science+Business Media, LLC.; 2012. p. 3-31.

Anief M. Apa yang Perlu Diketahui tentang Obat. Yogyakarta, Indonesia: Gadjah Mada University Press; 2007. 155 p.

Anief M. Penggolongan Obat Berdasarkan Khasiat dan Penggunaan. Yogyakarta, Indonesia: Gadjah Mada University Press; 2010. 70p.

Cheesman MJ, Ilanko A, Blonk B, Cock IE. Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extract/Compounds with Conventional Antibiotics the Solution? Pharmacognosy Reviews. 2017;11(22):57-72.

Hugo WB, Russell AD. Part 2: Antimicrobial Agents. In: Hugo WB, Russell AD, editors. Pharmaceutical Microbiology. 6th Edition. Oxford, UK: Blackwell Science, Ltd.; 1998. p. 90.

Lllmann H, Mohr K, Hein L, Bieger D, Wirth J. Color Atlas of Pharmacology. 3rd Edition. NY, USA: Thieme; 2005. 411p.

Greenwood D, Finch R, Davey P, Wilcox M. Antimicrobial Chemotherapy. 5th Edition. Oxford, UK: Oxford University Press. 413p.

WHO. Ten Threats to Global Health in 2019 [Internet]. Geneva, Switzerland: WHO; 2019

Amyes SGB. Magic Bullet, Lost Horizons: The Rise and Fall of Antibiotics. NY, USA: Taylor & Francis, Inc.; 2003. 273 p.

Power EGM. Bacterial Resistance to Antibiotics. In: Hugo WB, Russell AD, editors. Pharmaceutical Biology. 6th Edition. Oxford, UK: Blackwell Science, Ltd.; 1998. p. 191-200.

Llor C, Bjerrum L. Antimicrobial Resistance: Risk Associated with Antibiotic Overuse and Initiatives to Reduce the Problem. Therapeutic Advance in Drug Safety. 2014;5:229-241.

Hughes D, Andersson DI. Target Mutations Mediating Antibiotic Resistance. In: Hughes D, Andersson DI, editors. Antibiotic Development and Resistance. NY, USA: Taylor & Francis, Inc.; 2001. p. 23-36.

Guilfoile PG. Antibiotic-Resistant Bacteria. NY, USA: Chelsea House Publishers; 2007. 129p.

Subramani R, Narayanasamy M, Feussner K-D. Plant-Derived Antimicrobials to Fight Against Multi-Drug-Resistant Human Pathogens. 3 Biotech. 2017;7(3):1-15.

Taconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, the WHO Pathogens Priority List Working Group. 2017. Discovery, Research, and Development of New Antibiotics: the WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis. Lancet Infectious Disease. 2017;18(3):318-327.

Sarmah P, Dan MM, Adapa D, Sarangi TK. A Review on Common Pathogenic Microorganisms and Their Impact on Human Health. Electronic Journal of Biology. 2018;14(1):50-58.

Singleton P, Sainsbury D. Dictionary of Microbiology and Molecular Biology. 3rd Edition. West Sussex, UK: John Wiley & Sons, Ltd.; 2006. 904 p.

WHO. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics [Internet]. Geneva, Switzerland: WHO; 2017

Wilson M. Bacteriology of Humans: An Ecological Perspective. Oxford, UK: Blackwell Publishing, Ltd.; 2008. 364 p.

Boucher HW, Talbot GH, Bradley JS, Edward JE Jr, Gilbert D, Rice LB, Scheld M, Spelberg B, Barlett J. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clinical Infectious Diseases. 2009;48:1-12.

Ferri FF. Ferri's Clinical Advisor 2017: 5 Books in 1. PA, USA: Elsevier, Inc.; 2016. 1984 p.

Choudhury R, Panda S, Sharma S, Singh DV. Staphylococcal Infection, Antibiotic Resistance and Therapeutics. In: Pana M, editor. Antibiotic Resistant Bacteria A Continuous Challenge in the New Millennium. Rijeka, Croatia: InTech; 2012. p. 247-272.

Rohilla A. Handbook of Bacteriology. Jaipur, India: Oxford Book Company; 2010. 316 p.

Ehlers MM, Hughes JM, Kock MM. Prevalence of Carbapanemases in Acinobacter baumannii. In: Pana M, editor. Antibiotic Resistant Bacteria A Continuous Challenge in the New Millennium. Rijeka, Croatia: InTech; 2012. p. 213-246.

Prashanth K, Vasanth T, Saranathan R, Makki A. R, Pagal S. Antibiotic Resistance, Biofilms and Quorum Sensing in Acinobacter Species. In: Pana M, editor. Antibiotic Resistant Bacteria A Continuous Challenge in the New Millennium. Rijeka, Croatia: InTech; 2012. p. 179-212.

Schwaber M J, Carmeli Y. Carbapenem-Resistant Enterobacteriaceae. JAMA. 2008 Dec;300(24):2911-2913.

Malaty HM. Epidemiology of Helicobacter pylori Infection. In: Sutton P, Mitchell HM, editors. Helicobacter pylori in the 21st Century. Oxfordshire, UK: CABI; 2010. p. 1-12.

Ristuccia PA, Cunha BA. Klebsiella. Infection Control. 1984;5(7):343-348.

Podschun R, Ullmann U. Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors. Clinical Microbiology Reviews. 1998 Oct:589-603.

Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FSL, Hufnagle WO, Kowalik DJ, Lagrou M, Barber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK-S, Wu Z, Paulsen LT, Reizer J, Saier MH, Hancock REW, Lory S, Olson MV. Complete Genome Sequence of Pseudomonas aeruginosa PAO1, an Opportunistic Pathogen. Nature. 2000 Agustus 31;406(6799):959-964.

Van Doleweerd F. Salmonella enterica: Molecular Characterization, Role in Infectious Diseases, and Emerging Research. MA, USA: Nova Biomedical; 2018. 132 p.

Mendis K, Sina BJ, Marchesini P, Carter R. The Neglected Burden of Plasmodium vivax Malaria. The American Journal of Tropical Medicine and Hygiene. 2001 Jan 1;64(1_suppl):97-106.

Ljubojevic S, Skerlev M. HPV-Associated Diseases. Clinics in Dermatology. 2014 Mar 1;32(2):227-234.

WHO. Draft Thirteenth General Programme of Work, 2019-2023 [Internet]. Geneva, Switzerland: WHO; 2018

Iwu MM, Duncan AR, Okunji CO. New Antimicrobials of Plant Origin. In: Jannick J, editor. Perspectives on New Crops and New Uses. VA, USA: ASHS Press; 1999. p. 457-462.

Kumar S, Tripathi M. Antibiotic Resistant Bacteria: A Global Menace. Virology & Immunology Journal. 2017;1(3):000118.

Kaur S, Sharma C, Chaudhry S, Aman R. Antimicrobial Potential of Three Common Weeds of Kurukshetra: An in vitro Study. Research Journal of Microbiology. 2015;10(6):280.

Kabelik J. Introduction. In: Kabelik J, editor. Hemp as a Medicament (J. Kabelik [Ed.]). Olomouc, Czech Republic: Palacky University; 1955. p. 1-3.

Sarmadyan H, Solhi H, Hajimir T, Najarin-Araghi N, Ghaznavi-Rad E. Determination of the Antimicrobial Effect of Hydro-Alcoholic Extract of Cannabis sativa on Multiple Drug Resistant Bacteria Isolated from Nosocomial Infections. Iranian Journal of Toxicology. 2014;7(23):967-972.

Kabelik, J. History of the Medicinal Use of Hemp. In: Kabelik J, editor. Hemp as a Medicament. Olomouc, Czech Republic: Palacky University; 1955. p. 4-10.

Santavy F, Krejci Z. Properties of Isolated Substances: A Brief Survey of the Methods of Isolation and the Physical and Chemical Properties and Structures of the Isolated Antibacterial Substances. In: Kabelik J, editor. Hemp as a Medicament. Olomouc, Czech Republic: Palacky University; 1955. p. 11-21.

Chouinard F, Turcotte C, Guan X, Larose MC, Poirier S, Bouchard L, Provost V, Flamand L, Grandvaux N, Flamand N. 2-Arachidonoyl-glycerol- and Arachidonic acid-stimulated Neutrophils Release Antimicrobial Effectors against E. coli, S. aureus, HSV-1, and RSV. Journal of Leukocyte Biology. 2013 Feb;93(2):267-276.

Feldman M, Smoum R, Mechoulam R, Steinberg D. Antimicrobial potential of endocannabinoid and endocannabinoid-like compounds against methicillin-resistant Staphylococcus aureus. Scientific reports. 2018;8(1):1-0.

Cska B, Nmeth ZH, Mukhopadhyay P, Spolarics Z, Rajesh M, Federici S, Deitch EA, Btkai S, Pacher P, Hask G. CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis. PLoS ONE. 2009;4(7):e6409.

Das B, Mishra PC. Antibacterial Analysis of Crude Extracts from the Leaves of Tagetes erecta and Cannabis sativa. International Journal of Environmental Sciences. 2012;2(3):1605-1608.

Lone TA, Lone RA. Extraction of Cannabinoids from Cannabis sativa L. Plant and Its Potential Antimicrobial Activity. Universal Journal of Medicine and Dentistry. 2012;1:51-55.

Mkpenie VN, Essien EE, Udoh II. Effect of Extraction Conditions on Total Polyphenol Contents, Antioxidant and Antimicrobial Activities of Cannabis sativa L. Electronic Journal of Environment, Agricultural and Food Chemistry. 2012;11(4):300-307.

Singh V, Gupta R, Mittal A. Phytochemical, Antimicrobial, and Antioxidant Property of Cannabis sativa. World Journal of Pharmaceutical Research. 2017;6(16):454-463.

Ali EMM, Almagboul AZI, Khogali SME, Gergeir UMA. 2012. Antimicrobial Activity of Cannabis sativa L. Chinese Medicine. 2012;3:61-64.

Sumthong P. Antimicrobial Compounds as Side Products from Agricultural Processing Industry. Leiden University; 2007.

Mediavilla V. 1998. The Production of Essential Hemp Oil in Switzerland. In: Natural Fibres, Hemp, Flax and Other Bast Fibrous Plant-Production, Technology and Ecology. Symposium 1998 (Vol. 24, pp. 117-118).

Novak J, Zitterl-Eglseer K, Deans SG, Franz CM. Essential Oils of Different Cultivars of Cannabis sativa L. and Their Antimicrobial Activity. Flavour and Fragrance Journal. 2001;16(4):259-262.

Nissen L, Zatta A, Stefanini Il, Grandi S, Sgorbati B. Characterization and Antimicrobial Activity of Essential Oil of Industrial Hemp Varieties (Cannabis sativa L.). Fitoterapia. 2010;81(5):413-419.

Verma RS, Padalia RC, Verma SK, Chauhan A, Darokar MP. The Essential Oil of Bhang (Cannabis sativa L.) for Non-Narcotic Applications. Current Science. 2014; 107:645-650.

Abdelaziz AA. Studies on the Antimicrobial Activity of Cannabinoids (Bacillus megaterium). The Ohio State University; 1983.

Appendino G, Gibbons S, Giana A, Pagani A, Grassi G, Stavri M, Smith E, Rahman MM. Antibacterial Cannabinoids from Cannabis sativa: A Structure-Activity Study. Journal of Natural Products. 2008;71(8):1427-1430.

Khan BA, Warner P, Wang H. Antibacterial Properties of Hemp and Other Natural Fibre Plants: A Review. BioResources. 2014 M;9(2):3642-3659.

Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, Nisar MA, Alvi RF, Aslam MA, Qamar MU, Salamat MK. 2018. Antibiotic Resistance: A Rundown of a Global Crisis. Infection and Drug Resistance. 2018;11:1645.

OBrien TF, Clark A, Peters R, Stelling J. 2019. Why Surveillance of Antimicrobial Resistance Needs to be Automated and Comprehensive. Journal of Global Antimicrobial Resistance. 2019;1;17:8-15.

O'Neill J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. London, UK: The Review on Antimicrobial Resistance; 2014; 20p.

de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 Million People Die a Year Due to Antimicrobial Resistance by 2050? PLoS Medicine. 2016;13(11): e1002184.

Abdallah EM. Plants: An Alternative Source for Antimicrobials. Journal of Applied Pharmaceutical Science. 2011;1(6):16-20.

Chandra H, Bishnoi P, Yadav A, Patni B, Mishra AP, Nautiyal AR. Antimicrobial Resistance and the Alternative Resources with Special Emphasis on Plant-Based AntimicrobialsA Review. Plants. 2017;6(2):16.

Chit A, Grootendorst P. Policy to Encourage the Development of Antimicrobials. International Journal of Health Governance. 2018;23(2):101-110.

Travis A, Chernova O, Chernov V, Aminov R. Antimicrobial Drug Discovery: Lessons of History and Future Strategies. Expert Opinion on Drug Discovery. 2018;13(11):983-985.

Lewis K, Ausubel FM. Prospect for Plant-Derived Antibacterials. Nature Biotechnology. 2006;24(12): 1504-1507.

Upadhyay A, Upadhyaya I, Kollanoor-Johny A, Venkitanarayanan K. Combating Pathogenic Microorganisms Using Plant-Derived Antimicrobials: A Minireview of the Mechanistic Basis. BioMed Research International. 2014;2014:761741.

Iversen LL. The Science of Marijuana. 2nd Edition. NY, USA: Oxford University Press, Inc.; 2008. 273p.

Li H-L. The Origin and Use of Cannabis in Eastern Asia: Their Linguistic Cultural Implication. In: Rubin V, editor. Cannabis and Culture. The Hague, Netherlands: Mouton Publishers; 1975. p. 51-62.

Winterborne J. Medical Marijuana/Cannabis Cultivation: Trees of Life at the University of London. London, UK: Pukka Press, Ltd.; 2008. 493p.

Guiness World Records. Oldest Cultivated Plant for Products [Internet]. Guiness World Records; 2003.

Tandon C, Mathur P. Antimicrobial Efficacy of Cannabis sativa L. (Bhang): A Comprehensive Review. International Journal of Pharmaceutical Sciences Review and Research. 2017;44(1):94-100.

Glodowska M, Lyszcz M. Cannabis sativa L. and Its Antimicrobial Properties A Review. In: Badania i Rozwj M?odych Naukowcw w Polsce Agronomia i ochrona ro?lin [Conference Proceeedings on the Internet]; 2016 Nov; Lublin, Polandia. Pozna?, Polandia: M?odzi Naukowcy; 2016. p. 77-82.

Ventola CL. The Antibiotic Resistance Crisis, Part 1: Causes and Threats. Pharmacy and Therapeutics. 2015;40(4):277-283.

Fernandes P, Martens E. Antibiotics in Late Clinical Development. Biochemical Pharmacology. 2017;1;133:152-163.

Rolain J-M, Abat C, Jimeno M-T, Fournier P-E, Raoult D. Do We Need New Antibiotics? Clinical Microbiology and Infection. 2016 1;22(5):408-415.

Hernndez-Cervantes R, Mndez-Daz M, Prospro-Garca , Morales-Montor J. Immunoregulatory Role of Cannabinoids during Infectious Disease. Neuroimmunomodulation. 2017;24(4-5):183-199.

Somerset, SB. Thailand Legalizes Medical Marijuana and Kratom [Internet]. NJ, USA: Forbes; 2018.

Kaur M. Legalise Medical Marijuana? Only If Proven Safe and Effective [Internet]. Selangor, Malaysia: The Star; 2018.

Wargadireja AT. The Battle of Legal Medical Marijuana Hits Malaysia [Internet]. NY, USA: VICE; 2019.

Bourque A. Thailand's Legalization of Medical Cannabis Proves One Very Important Thing [Internet]. NJ, USA: Forbes; 2018.

Freeman J, Konglang A. Thailand Marijuana Festival Has Visitors on a High [Internet]. Jakarta, Indonesia: The Jakarta Post; 2019.

Poonsuwan W. Thai Law: Foreigners and the Medical Marijuana Law, Explained [Internet]. Bangkok, Thailand: Khaosod English; 2019.

France-Presse A. Thailand to Start Testing Medical Marijuana on Patients [Internet]. Jakarta, Indonesia: The Jakarta Post; 2019.

DOI: https://doi.org/10.30596/bf.v6i3.5632

DOI (PDF): https://doi.org/10.30596/bf.v6i3.5632.g6462


  • There are currently no refbacks.


Gedung Kampus 1 Fakultas Kedokteran Universitas Muhammadiyah Sumatera Utara | UMSU

Lantai II,Laboratorium Farmakologi dan Terapi FK UMSU-Jalan Gedung Arca No. 53 Medan-Sumatera Utara ,

Kode Pos 20217 Kontak: 0812-6208-2844,E-mail: farmatera@umsu.ac.id

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Statcounter View My Stats Buletin Farmatera